PropThink: QCOR Beat Down To Reverse; Synacthen Toxic To Infants, Not A Real Threat

PropThink: QCOR Beat Down To Reverse; Synacthen Toxic To Infants, Not A Real Threat

[ACN Newswire] – By David MoskowitzShares of Questcor Pharmaceuticals (NASDAQ:QCOR) are under pressure Friday, down 10% in morning trading on news that unknown drug company Cerium Pharmaceuticals has received Orphan Drug … more

View todays social media effects on QCOR

View the latest stocks trending across Twitter. Click to view dashboard

Share this post